DE69633133D1 - TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren - Google Patents

TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren

Info

Publication number
DE69633133D1
DE69633133D1 DE69633133T DE69633133T DE69633133D1 DE 69633133 D1 DE69633133 D1 DE 69633133D1 DE 69633133 T DE69633133 T DE 69633133T DE 69633133 T DE69633133 T DE 69633133T DE 69633133 D1 DE69633133 D1 DE 69633133D1
Authority
DE
Germany
Prior art keywords
peptide
smooth muscle
amino acid
muscle cells
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633133T
Other languages
English (en)
Other versions
DE69633133T2 (de
Inventor
Yo Nakahara
Saburo Hara
Yuichi Kamikubo
Sumiyo Takemoto
Seiji Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE69633133D1 publication Critical patent/DE69633133D1/de
Publication of DE69633133T2 publication Critical patent/DE69633133T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69633133T 1995-10-24 1996-10-23 TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren Expired - Fee Related DE69633133T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30079295 1995-10-24
JP30079295 1995-10-24
PCT/JP1996/003080 WO1997015598A1 (en) 1995-10-24 1996-10-23 Novel peptide

Publications (2)

Publication Number Publication Date
DE69633133D1 true DE69633133D1 (de) 2004-09-16
DE69633133T2 DE69633133T2 (de) 2005-07-28

Family

ID=17889159

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633133T Expired - Fee Related DE69633133T2 (de) 1995-10-24 1996-10-23 TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren

Country Status (9)

Country Link
US (1) US6191113B1 (de)
EP (1) EP0867450B1 (de)
JP (1) JP3930050B2 (de)
KR (1) KR100465222B1 (de)
AT (1) ATE273322T1 (de)
AU (1) AU719366B2 (de)
CA (1) CA2232240C (de)
DE (1) DE69633133T2 (de)
WO (1) WO1997015598A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0933423B1 (de) * 1996-02-23 2007-08-22 Mochida Pharmaceutical Co., Ltd. Meltrine
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
TWI257307B (en) * 2000-07-12 2006-07-01 Orthologic Corp Pharmaceutical composition for cardiac tissue repair
PL208666B1 (pl) 2001-07-13 2011-05-31 Cms Peptides Patent Holding Company Ltd Środek farmaceutyczny zawierający peptyd, sposób wytwarzania środka farmaceutycznego i zastosowanie peptydu
WO2003060131A1 (fr) * 2002-01-09 2003-07-24 Suntory Limited Transferase gn-t de sucre presentant un effet angiogenique
EP1539214A4 (de) * 2002-07-02 2008-01-02 Orthologic Corp Thrombinpeptidderivate
TWI353252B (en) 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
US8586525B2 (en) 2005-07-26 2013-11-19 Cms Peptides Patent Holding Company Limited Biologically active peptides and their new uses
CA2663547C (en) * 2006-09-22 2020-08-25 Orthologic Corp. Method of treating endothelial dysfunction
WO2009142679A2 (en) * 2008-03-26 2009-11-26 Orthologic Corp. Methods for treating acute myocardial infarction
CN103080135B (zh) * 2010-06-30 2017-06-13 诺沃—诺迪斯克有限公司 能够特异性结合组织因子途径抑制剂的抗体
US9228022B2 (en) 2010-06-30 2016-01-05 Novo Nordisk A/S Antibodies that are capable of specifically binding tissue factor pathway inhibitor
PL236566B1 (pl) 2012-12-17 2021-01-25 Univ Jagiellonski Peptyd chemerynowy, kompozycja farmaceutyczna zawierająca taki peptyd, oraz jego zastosowanie
WO2019176860A1 (ja) * 2018-03-15 2019-09-19 東レ株式会社 細胞接着性材料

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849536A (en) * 1990-03-02 1998-12-15 Bio-Technology General Corp. Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same
US5254536A (en) * 1992-01-10 1993-10-19 The Du Pont Merck Pharmaceutical Company Therapeutic utility of plasminogen activator inhibitor-1 to control bleeding
AU5715194A (en) 1992-12-04 1994-07-04 N.V. Innogenetics S.A. New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria
JP3428687B2 (ja) 1993-06-30 2003-07-22 財団法人化学及血清療法研究所 組織因子凝固系インヒビターの調製法
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
US5589359A (en) * 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
JPH0859698A (ja) * 1994-08-15 1996-03-05 Teijin Ltd 血液凝固調節能を有する新規ペプチド
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
JPH09124506A (ja) 1995-08-29 1997-05-13 Chemo Sero Therapeut Res Inst 組織因子凝固系インヒビター含有動脈硬化治療剤
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation

Also Published As

Publication number Publication date
KR19990066965A (ko) 1999-08-16
ATE273322T1 (de) 2004-08-15
CA2232240A1 (en) 1997-05-01
DE69633133T2 (de) 2005-07-28
JP3930050B2 (ja) 2007-06-13
AU719366B2 (en) 2000-05-04
EP0867450A1 (de) 1998-09-30
EP0867450B1 (de) 2004-08-11
EP0867450A4 (de) 2000-01-19
KR100465222B1 (ko) 2005-05-17
AU7335796A (en) 1997-05-15
US6191113B1 (en) 2001-02-20
WO1997015598A1 (en) 1997-05-01
CA2232240C (en) 2007-01-16

Similar Documents

Publication Publication Date Title
DE69633133D1 (de) TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren
DE69028535D1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
DE69627704D1 (en) Protegrine
CA2153789A1 (en) Biologically active tgf-.beta.1 and tgf-.beta.2 peptides
CA2081450A1 (en) Biologically active peptides containing d-2-alkyltrypthophan
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
EP0711305A4 (de) Protegrine
DE69130696D1 (de) Ein neues, biologisch aktives vom Huhn stammendes Peptid (Huhn-CNP)
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
DE69126049D1 (de) Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C
HU895788D0 (en) Process for producing peptides and medical products containing them
HUT53125A (en) Process for producing peptides with anticoagulant activity
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DE69126563T2 (de) Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
EP0241136A3 (de) Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
KR950701347A (ko) 신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine)
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
EP0446361A4 (en) Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
DE3876788D1 (de) Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.
RU93041779A (ru) Средство для лечения иммунодефицитных состояний
RU93056862A (ru) Способ предотвращения рестеноза или снижения его степени

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee